• Explore /
  • Poster
  • / Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors in non-small cell lung cancer.

Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors in non-small cell lung cancer.

Abstract Video & Slides Poster

Authors

null

Yuki Miyai

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Nagoya, Japan

Yuki Miyai , Atsushi Enomoto , Yuichi Ando , Masahide Takahashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Tissue-Based Biomarkers

Citation

J Clin Oncol 38: 2020 (suppl; abstr 3118)

DOI

10.1200/JCO.2020.38.15_suppl.3118

Abstract #

3118

Poster Bd #

182

Abstract Disclosures

Similar Posters

First Author: Alex K. Bryant

First Author: Bassel Nazha

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

First Author: Laurent Mhanna

First Author: Yukiko Shimoda Igawa